Dx Deals: Labcorp Continues Dealmaking with Incyte Asset Acquisition in Washington State
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
Read this overview of legislation and regulations governing laboratory marketing practices and learn tips to ensure these activities remain compliant
As of March 1, 2026, CMS will move CLIA away from paper-based transactions to improve efficiency and payments
The board was eliminated as part of a sweeping reordering of the Department of Health and Human Services
A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.
The role at this point is theoretical, but our editors asked AI for help in drafting what the position might entail
While still in the early stages, Clinical Lab 2.0’s pitch for this new position fits with the need to better use lab data
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight
Recent inroads into testing of water for dialysis equipment illustrates Quest’s expanded scope with deals
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes